Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma

Wenjiao Jin(Renji Hospital), Hong Li(Central South University of Forestry and Technology)
International Journal of Biological Sciences
January 1, 2023
Cited by 19


Related Papers